Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday
Gainers
Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday’s Mid-Day Session
Gainers
MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.
Why Allakos Shares Are Rising Sharply
Allakos Inc (NASDAQ: ALLK) shares are trading higher by 29.26% to $5.92 during Monday's trading session after the company priced an underwritten offering of roughly 29.88 million shares of common stock at $5.02 per share.
Allakos Announces Initiation Of Phase 2b Clinical Trial Of Subcutaneous Lirentelimab In Chronic Spontaneous Urticaria
Allakos Inc. (NASDAQ:ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today announced it has initiated a Phase 2b clinical trial to
Important Biotech Catalysts For September 9, 2022 – End Of The Day Summary
The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ:SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to…
After Disappointing Data, Allakos Discontinues Work On Lirentelimab In Eosinophilic Gastrointestinal Diseases
Allakos Inc (NASDAQ: ALLK) has reported data from the EoDyssey Phase 3 study of lirentelimab in patients with eosinophilic duodenitis (EoD).
